Executive appointments

Professor Janabi will begin his five-year term on 30 June 2025, taking over from Dr. Matshidiso Moeti, who has led WHO’s African Region since 2015 and has played a key role in advancing health across the continent.

Dr. Olaro assumes this critical leadership role at a time when Uganda’s Ministry of Health is focused on implementing reforms to achieve universal health coverage, strengthen health infrastructure, and improve access to quality healthcare for all citizens.

Lars Fruergaard Jørgensen, who has served as CEO since January 2017, will step down from his role by mutual agreement with the Board.

His nomination will now be submitted for formal appointment during the 157th session of the WHO Executive Board, scheduled to take place from May 28 to 29, 2025, in Geneva.

Dr. Boutaoui is recognized for her expertise in AI-driven healthcare innovation and strategic growth, making her a valuable asset to ProvenMed’s advisory board.

This leadership transition marks a strategic pivot for Clean Biologics, positioning the company to refine its commercial approach and strengthen its presence in the promising US market for biotherapies.

Dr. Ogwell, who is well-known for his knowledge of non-communicable illnesses, health emergencies, health policy, and global health diplomacy, has spearheaded international discussions to influence policy reforms throughout Africa.

In his new role, Dr. Ndenzako will lead the implementation of the WHO Country Cooperation Strategy (CCS) 2024–2027, ensuring that WHO’s efforts are closely aligned with Botswana’s National Development Plan.

Mr. Siele has been serving as the Acting CEO since July 2024, while also holding the position of Human Resources and Administration Director since January 2022.